Literature DB >> 8300862

The HLA-Dw2 haplotype segregates closely with multiple sclerosis in multiplex families.

J Hillert1, T Käll, M Vrethem, S Fredrikson, M Ohlson, O Olerup.   

Abstract

Multiple sclerosis (MS) is associated with the HLA class II specificity Dw2, but the importance of its influence has been questioned, since sib-pair analysis has failed to show linkage with this haplotype. However, the use of 'identity by descent' (IBD) analysis may not be ideal, since it does not make use of the facts that (i) the Dw2-haplotype is the only haplotype with a confirmed role in MS, and (ii) it performs its influence in a dominant manner. We have investigated nine Swedish multiplex MS families. In eight of the families, the Dw2 haplotype occurred in MS patients. Within these families, Dw2 was shared by all 17 individuals with MS. In a compilation of 48 published multiplex MS families in which at least one patient carried Dw2, only three of 107 individuals with MS did not carry the Dw2 haplotype. This indicates that the Dw2 haplotype, when present in familial MS, may confer a stronger influence in MS susceptibility than generally recognized.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8300862     DOI: 10.1016/0165-5728(94)90219-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.

Authors:  Kazuyuki Kawamura; Katherine A McLaughlin; Robert Weissert; Thomas G Forsthuber
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

2.  Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis.

Authors:  Joel N H Stern; Zsolt Illés; Jayagopala Reddy; Derin B Keskin; Masha Fridkis-Hareli; Vijay K Kuchroo; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

3.  Second-generation peptidomimetic inhibitors of antigen presentation effectively treat autoimmune diseases in HLA-DR-transgenic mouse models.

Authors:  Edward F Rosloniec; Tilmann Brandstetter; Sigmar Leyer; Franz-Werner Schwaiger; Zoltan A Nagy
Journal:  J Autoimmun       Date:  2006-11-01       Impact factor: 7.094

4.  Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein.

Authors:  L Gauthier; K J Smith; J Pyrdol; A Kalandadze; J L Strominger; D C Wiley; K W Wucherpfennig
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

5.  Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein.

Authors:  K J Smith; J Pyrdol; L Gauthier; D C Wiley; K W Wucherpfennig
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.